551 related articles for article (PubMed ID: 2420892)
21. Alternative mechanisms of natural killer cell activation during herpes simplex virus infection.
Paya CV; Schoon RA; Leibson PJ
J Immunol; 1990 Jun; 144(11):4370-5. PubMed ID: 2160501
[TBL] [Abstract][Full Text] [Related]
22. NK cells contribute to the early clearance of HSV-1 from the lung but cannot control replication in the central nervous system following intranasal infection.
Reading PC; Whitney PG; Barr DP; Smyth MJ; Brooks AG
Eur J Immunol; 2006 Apr; 36(4):897-905. PubMed ID: 16552715
[TBL] [Abstract][Full Text] [Related]
23. Natural cytotoxicity against mouse hepatitis virus-infected target cells. I. Correlation of cytotoxicity with virus binding to leukocytes.
Holmes KV; Welsh RM; Haspel MV
J Immunol; 1986 Feb; 136(4):1446-53. PubMed ID: 3003198
[TBL] [Abstract][Full Text] [Related]
24. Protection against murine neonatal herpes simplex virus infection by lymphokine-treated human leukocytes.
Kohl S
J Immunol; 1990 Jan; 144(1):307-12. PubMed ID: 2153165
[TBL] [Abstract][Full Text] [Related]
25. Interleukin-12- and gamma interferon-dependent innate immunity are essential and sufficient for long-term survival of passively immunized mice infected with herpes simplex virus type 1.
Vollstedt S; Franchini M; Alber G; Ackermann M; Suter M
J Virol; 2001 Oct; 75(20):9596-600. PubMed ID: 11559791
[TBL] [Abstract][Full Text] [Related]
26. The effect of the Cmv-1 resistance gene, which is linked to the natural killer cell gene complex, is mediated by natural killer cells.
Scalzo AA; Fitzgerald NA; Wallace CR; Gibbons AE; Smart YC; Burton RC; Shellam GR
J Immunol; 1992 Jul; 149(2):581-9. PubMed ID: 1378069
[TBL] [Abstract][Full Text] [Related]
27. Elevated natural killer cell-mediated cytotoxicity, plasma interferon, and tumor cell rejection in mice persistently infected with lymphocytic choriomeningitis virus.
Bukowski JF; Biron CA; Welsh RM
J Immunol; 1983 Aug; 131(2):991-6. PubMed ID: 6190947
[TBL] [Abstract][Full Text] [Related]
28. Role of interferon in natural kill of HSV-1-infected fibroblasts.
Fitzgerald PA; von Wussow P; Lopez C
J Immunol; 1982 Aug; 129(2):819-23. PubMed ID: 6177785
[TBL] [Abstract][Full Text] [Related]
29. Contributions of antibody and T cell subsets to protection elicited by immunization with a replication-defective mutant of herpes simplex virus type 1.
Morrison LA; Knipe DM
Virology; 1997 Dec; 239(2):315-26. PubMed ID: 9434723
[TBL] [Abstract][Full Text] [Related]
30. Natural killer cell cytokine production, not cytotoxicity, contributes to resistance against blood-stage Plasmodium chabaudi AS infection.
Mohan K; Moulin P; Stevenson MM
J Immunol; 1997 Nov; 159(10):4990-8. PubMed ID: 9366426
[TBL] [Abstract][Full Text] [Related]
31. Depletion of NK cells results in disseminating lethal infection with Bordetella pertussis associated with a reduction of antigen-specific Th1 and enhancement of Th2, but not Tr1 cells.
Byrne P; McGuirk P; Todryk S; Mills KH
Eur J Immunol; 2004 Sep; 34(9):2579-88. PubMed ID: 15307190
[TBL] [Abstract][Full Text] [Related]
32. Severe herpes virus (HSV-2) infection in two patients with myelodysplasia and undetectable NK cells and plasmacytoid dendritic cells in the blood.
Dalloul A; Oksenhendler E; Chosidow O; Ribaud P; Carcelain G; Louvet S; Massip P; Lebon P; Autran B
J Clin Virol; 2004 Aug; 30(4):329-36. PubMed ID: 15163423
[TBL] [Abstract][Full Text] [Related]
33. Innate and acquired immunity to herpes simplex virus type 1.
Halford WP; Veress LA; Gebhardt BM; Carr DJ
Virology; 1997 Sep; 236(2):328-37. PubMed ID: 9325240
[TBL] [Abstract][Full Text] [Related]
34. Role of interferon in the protective effect of an immunomodulator derived from the Su strain of Streptococcus pyogenes A3 against viral myocarditis in mice.
Kanda T; Yokoyama T; Suzuki T; Murata K
Arzneimittelforschung; 1993 Jan; 43(1):80-3. PubMed ID: 7680562
[TBL] [Abstract][Full Text] [Related]
35. Induction of innate immunity against herpes simplex virus type 2 infection via local delivery of Toll-like receptor ligands correlates with beta interferon production.
Gill N; Deacon PM; Lichty B; Mossman KL; Ashkar AA
J Virol; 2006 Oct; 80(20):9943-50. PubMed ID: 17005672
[TBL] [Abstract][Full Text] [Related]
36. Tunicamycin enhances virus replication and inhibits antiviral activity of interferon in mice: correlation with natural killer cells.
Singh VK; Damewood GP; Friedman RM; Maheshwari RK
J Exp Pathol; 1987; 3(1):19-33. PubMed ID: 2445942
[TBL] [Abstract][Full Text] [Related]
37. Positively selected Leu-11a (CD16+) cells require the presence of accessory cells or factors for the lysis of herpes simplex virus-infected fibroblasts but not herpes simplex virus-infected Raji.
Fitzgerald-Bocarsly P; Feldman M; Curl S; Schnell J; Denny T
J Immunol; 1989 Aug; 143(4):1318-26. PubMed ID: 2526183
[TBL] [Abstract][Full Text] [Related]
38. Intrinsic resistance to viral infection. Mouse macrophage restriction of herpes simplex virus replication.
Sarmiento M
J Immunol; 1988 Oct; 141(8):2740-8. PubMed ID: 2844905
[TBL] [Abstract][Full Text] [Related]
39. High cytotoxic activity against herpes simplex virus type 1 infected targets found in murine peritoneum.
Brownridge E; Lopez C
Nat Immun Cell Growth Regul; 1986; 5(6):294-304. PubMed ID: 2432414
[TBL] [Abstract][Full Text] [Related]
40. Demonstration of the antiviral role of natural killer cells in vivo with a natural killer cell-specific monoclonal antibody (NK 1.1).
Welsh RM; Dundon PL; Eynon EE; Brubaker JO; Koo GC; O'Donnell CL
Nat Immun Cell Growth Regul; 1990; 9(2):112-20. PubMed ID: 2352539
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
